In our study, the relationship between the CD56 and CD117 aberrant expressions in malignant plasma cells in MM patients at the time of diagnosis and clinical and laboratory parameters were retrospectively assessed. The gene discussed is NCAM1; the disease is Miyoshi myopathy.